← Leaderboards
Erik J Forsberg
Regenerative Medical Solutions, Inc.
$2,389,252
Attributed
$2,389,252
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2014–16$2M$1.5M$1M$500K$0
'14
'15
'16
Funding mix
By agency
NIH$2,389,252 · 5
By mechanism
R44$1,499,949 · 1
R43$889,303 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Beta Cell”
- Jeffrey P Krischer · University Of South Florida$200,020,568
- John M Lachin · George Washington University$137,809,898
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Mark A Magnuson · Vanderbilt University$88,190,667
- Mitchell A. Lazar · University Of Pennsylvania$60,855,549
- Randall J Bateman · Washington University$46,897,850
Research focus
Beta CellDiabetes MellitusInsulinInsulin SecretionDrug DiscoveryCellsInduced Pluripotent Stem CellIsletRegenerativeProtocols DocumentationMeetingsGlucoseMedicalCell LineBaseScreeningGene ExpressionSourcePharmacologic SubstanceCell PhysiologyHigh Throughput ScreeningPancreasReportingToxicity Tests
Grant awards (6)
Human induced pluripotent stem cell-derived beta-cells for drug and toxicity testing$800,794
R44 · FY2016 · DK · contact PI
Development of a rapid and inexpensive luciferase-based high throughput screening assay to identify compounds that alter pancreatic β cell function$224,964
R43 · FY2016 · DK · contact PI
Diabetes drug screening platforms using patient pancreatic islet-like cells generated from induced pluripotent stem cells$224,930
R43 · FY2016 · DK · contact PI
Engineered pancreatic endocrine cells that report beta cell toxicity for use in high throughput screening applications$217,389
R43 · FY2016 · DK · contact PI
Human induced pluripotent stem cell-derived beta-cells for drug and toxicity testing$699,155
R44 · FY2015 · DK · contact PI
Human Induced Pluripotent Stem Cell-Derived Beta-Cells for Drug and Toxicity Testing$222,020
R43 · FY2014 · DK · contact PI